77019-8
Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
Active
Term Description
This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT panel, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 18 and 21 aneuploidies. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.
Source: Regenstrief LOINC
Part Description
LP150045-5 Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977. PMID: 271968 Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost. PMID: 18576944 Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template. PMID: 20858600
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
77019-8 | Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing | |||
Indent77014-9 | Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative | |||
Indent77015-6 | Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative |
Fully-Specified Name
- Component
- Noninvasive prenatal fetal 18 & 21 aneuploidy panel
- Property
- -
- Time
- Pt
- System
- Plas.cfDNA
- Scale
- -
- Method
- Sequencing
Additional Names
- Short Name
- NIP fet 18+21 aneu pnl Plas.cfDNA Seq
- Display Name
- Noninvasive prenatal fetal 18 and 21 aneuploidy panel Sequencing (cfDNA)
- Consumer Name Alpha Get Info
- Fetal Noninvasive prenatal fetal 18 and 21 aneuploidy panel
Basic Attributes
- Class
- PANEL.MOLPATH
- Type
- Laboratory
- First Released
- Version 2.52
- Last Updated
- Version 2.73
- Order vs. Observation
- Order
- Panel Type
- Panel
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Panel prenatal no invasivo para aneuploidías 18 y 21: |
es-MX | Spanish (Mexico) | Panel de aneuploidía prenatal fetal 18 y 21 no invasivo: |
fr-FR | French (France) | Aneuploïdies foetales prénatales non invasives 18 et 21 panel: |
it-IT | Italian (Italy) | Aneuploidia fetale 18 & 21, panel prenatale non invasivo: Synonyms: DNA libero circolante nel plasma Panel prenatale non invasivo per aneuploidia 18 e Patologia molecolare Plasma Punto nel tempo (episodio) Set di prescrizione patologia molecolare |
zh-CN | Chinese (China) | 无创性产前胎儿 18 与 21 非整倍体性组套: Synonyms: 分子病理学; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=77019-8 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/77019-8
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright